Top Markets
Coin of the day
CNS Pharmaceuticals, Inc. CNS Pharmaceuticals, Inc.

CNS Pharmaceuticals, Inc.

CNSP
Clasificación en acciones #33273
CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily... CNS Pharmaceuticals, Inc. is a clinical-stage pharmaceutical firm primarily focused on developing innovative anti-cancer therapies for tumors affecting the brain and central nervous system. Its primary investigational compound, Berubicin, an anthracycline, is currently progressing through Phase I and II clinical trials as a potential treatment for glioblastoma multiforme, an aggressive form of brain cancer. To bolster its research and development initiatives, the company has entered into several strategic agreements. These include licensing arrangements with Houston Pharmaceuticals, Inc., The University of Texas M.D. Anderson Cancer Center, and Animal Life Sciences, LLC. Additionally, CNS Pharmaceuticals has a development agreement in place with WPD Pharmaceuticals Inc. and a collaborative partnership with Reata Pharmaceuticals, Inc. The company was founded in 2017 and is headquartered in Houston, Texas.
Precio por acción
$5.47
Última sincronización: 2026-08-14
Capitalización bursátil
$7.99M
Cambio (1 día)
6.21%
Cambio (1 año)
7.47%
País
US
Comercio CNS Pharmaceuticals, Inc. (CNSP)

Categoría

Historial de desdoblamientos de acciones de CNS Pharmaceuticals, Inc. (CNSP)
La acción CNS Pharmaceuticals, Inc. (símbolo: CNSP) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 17, 2026.
Una acción CNSP comprada antes de Aug 17, 2026 equivaldría hoy a 0 acciones CNSP.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE